Work

16 01 Base Architecture Hepatocellular Carcinoma HCV-related

Year: 2026

Type: article

Abstract: CTNNB1-mutant HCC represents 20-40% of hepatocellular carcinomas and exhibits distinct metabolic characteristics compared to other molecular subtypes [Llovet et al., 2021, Zucman-Rossi et al., 2022]. The constitutivestabilization of-catenin through exon 3 mutations fundamentally reshapes cellular metabolism, organellar architecture, and ecosystem interactions [Rebouissou et al., 2016].Current therapeutic approaches remain largely empirical, lacking quantitative frameworks to predict tumorresponse and optimal intervention timing. This Framework Tries Modestly to Take a snapshot of this Carconomas Dinamic and Base architecture as a coeherent logical organizing system.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.18167063

Author: Stefan, Ionut Alexandru

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7119500836

FWCI:

Cites:

Cited by:

Related to: